High-Dose Convalescent Plasma for Treatment of Severe COVID-19

Daniele Focosi; Arturo Casadevall

doi:10.3201/eid2805.220191

High-Dose Convalescent Plasma for Treatment of Severe COVID-19

Daniele Focosi
, Arturo Casadevall

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1083
Number of pages	1
Journal	Emerging infectious diseases
Volume	28
Issue number	5
DOIs	https://doi.org/10.3201/eid2805.220191
State	Published - May 2022

ASJC Scopus subject areas

Epidemiology
Microbiology (medical)
Infectious Diseases

Access to Document

10.3201/eid2805.220191

Cite this

@article{f566f559d5d44d64b30ce191721be8dd,

title = "High-Dose Convalescent Plasma for Treatment of Severe COVID-19",

author = "Daniele Focosi and Arturo Casadevall",

year = "2022",

month = may,

doi = "10.3201/eid2805.220191",

language = "English (US)",

volume = "28",

pages = "1083",

journal = "Emerging infectious diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "5",

}

TY - JOUR

T1 - High-Dose Convalescent Plasma for Treatment of Severe COVID-19

AU - Focosi, Daniele

AU - Casadevall, Arturo

PY - 2022/5

Y1 - 2022/5

UR - https://www.scopus.com/pages/publications/85128681238

UR - https://www.scopus.com/pages/publications/85128681238#tab=citedBy

U2 - 10.3201/eid2805.220191

DO - 10.3201/eid2805.220191

M3 - Letter

C2 - 35447061

AN - SCOPUS:85128681238

SN - 1080-6040

VL - 28

SP - 1083

JO - Emerging infectious diseases

JF - Emerging infectious diseases

IS - 5

ER -

High-Dose Convalescent Plasma for Treatment of Severe COVID-19

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this